Biohorizons blazes a trail at ADI Congresson 21st July 2019
Naomi Pleasants reports on the ADI Team Congress, where Biohorizons expertly met the association’s message of shaping the future of implant dentistry
This year’s ADI Team Congress was hailed a great success for Biohorizons, with the company meeting so many interested dental professionals at its stand.
In addition, the presentations led by Dr Stephen Jacobs and Dr Ignacio Sanz Sánchez on augmentation techniques and implant treatment planning, were well received.
Dr Jacobs discussed how to select the grafting technique most appropriate to different clinical situations, demonstrating the innovative methods and materials. He also presented his latest research data on implant stability in grafted sockets.
Dr Sánchez explored the advantages and newest techniques for successful treatment planning with computer-assisted surgery. His session covered how guided software is used to plan and control implant position and size to create aesthetic, predictable final restorations.
In a spin
Meanwhile, on the stand, alongside Biohorizons comprehensive range of implants and regeneration solutions, visitors got a first look at Intraspin, an FDA-cleared and CE-marked medical device for the production of leukocyte- and platelet-rich fibrin (L-PRF).
Demonstrations of this system highlighted a simplified chairside procedure to produce L-PRF and explained its benefits, with visitors realising it is a game-changer for implant dentists. L-PRF is a 3D autogenous combination of platelets, growth factors, proteins, leukocytes and cytokines incorporated into a natural fibrin network derived from the patient’s blood (Schliephake et al, 2018).
A simplified chairside procedure results in the production of a thin, compressed layer of platelet-rich fibrin that is strong, pliable, and suitable for suturing. The presence of these proteins has been reported to produce rapid healing, especially during the critical first seven days after placement (Dohan Ehrenfest et al, 2009). This network promotes more efficient cell migration and proliferation without chemical or bovine thrombin additives (Dohan et al, 2006).
Offering a practical application of L-PRF with the demonstration, the Intraspin system establishes a three-step protocol for drawing and spinning the patient’s blood, removing the fibrin clot, and processing it in the Xpression fabrication kit. A thin, compressed layer of L-PRF or plugs for extraction sites can then be formed, using either the internal plate or the piston assembly.
L-PRF advantages include:
• No anticoagulant
• No bovine thrombin
• No heating
• No pipetting
• No second spin
• No chemical additives.
With data suggesting a promising role for platelet concentrates in the clinical setting of wound healing and tissue regeneration, and evidence supporting a strong pro-angiogenic effect of L-PRF in vitro and in vivo (Ratajczak et al, 2018), it was suggested time has come for implant dentists to consider using L- PRF when appropriate for the treatment.
Naomi Pleasants is marketing manager at Biohorizons UK and Ireland.